Gene: LRRC75A
Official Full Name: leucine rich repeat containing 75Aprovided by HGNC
Gene Summary: Predicted to enable ubiquitin-like ligase-substrate adaptor activity. Predicted to be involved in proteasome-mediated ubiquitin-dependent protein catabolic process. Predicted to be part of Cul2-RING ubiquitin ligase complex. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO16437 | LRRC75A Knockout cell line (HeLa) | Human | LRRC75A | 1:3~1:6 | Negative | Online Inquiry |
KO16438 | LRRC75A Knockout cell line (HCT 116) | Human | LRRC75A | 1:2~1:4 | Negative | Online Inquiry |
KO16439 | LRRC75A Knockout cell line (HEK293) | Human | LRRC75A | 1:3~1:6 | Negative | Online Inquiry |
LRRC75A Gene Knockout Cell Lines are genetically engineered cellular models that feature targeted deletion of the LRRC75A gene, a critical gene implicated in cellular signaling and potentially in various disease processes. These specialized cell lines serve as valuable tools for studying the functional role of the LRRC75A protein in cellular physiology and pathophysiology.
The mechanism behind these knockout cell lines is based on advanced gene-editing techniques, such as CRISPR-Cas9, which allow for precise modifications in the genome. By excising the LRRC75A gene, researchers can observe the resulting phenotypic and biochemical changes, thereby elucidating the gene's role in normal cell function, as well as its contributions to disease states such as cancer and neurodegenerative disorders.
The scientific importance of LRRC75A Gene Knockout Cell Lines is underscored by their wide applicability in both research and clinical settings. They are essential for dissecting signaling pathways, validating drug targets, and understanding the underlying mechanisms of diseases. By employing these cell lines, researchers can gain insights into the interactions between the LRRC75A protein and other cellular components, aiding in the development of novel therapeutic strategies.
One of the unique selling points of our LRRC75A Gene Knockout Cell Lines is the high fidelity and efficiency of the knockout achieved through our proprietary editing technology, ensuring reproducibility and reliability in experimental outcomes. Compared to traditional models or other gene knockout strategies, our product offers a user-friendly approach that enhances validation studies, saves time, and reduces costs through optimized workflows.
For researchers, clinicians, and pharmaceutical companies, these cell lines represent a transformative resource for better understanding the complexities of gene function and disease mechanisms. Their ability to facilitate groundbreaking discoveries can significantly advance scientific knowledge and contribute to the development of innovative therapeutics.
Our company is dedicated to providing high-quality biological products that empower the scientific community. With a focus on precision, reproducibility, and customer support, we are committed to enhancing research capabilities and driving forward the frontier of biological science.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.